Congress 2014 has ended
Back To Schedule
Friday, May 2 • 6:00am - 7:30am
Persistent and Breakthrough Pain Individualizing Opioid Therapy for Fluctuating Cancer Pain

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

This evidence-based best-practices program will foster discussion and debate among experts dedicated to improving the care of patients with cancer pain. Using brief summary didactics, peer-to-peer conversations, and case studies shaped by audience input, three recognized thought leaders in the field—each with established expertise in the diagnosis and individualized treatment of various cancer pain syndromes—will participate in an interactive, case-based discussion. The expert panel will share interpretive insights into practice guidelines as well as their own clinical strategies for assessing and differentially diagnosing breakthrough pain (BTP).

Recommendations for optimizing opioid-based therapy in diverse patient types and the class-wide Risk Evaluation and Mitigation Strategy for transmucosal immediate-release fentanyl medications will be addressed. Clinical cases will address pressing, real-world issues faced by oncology nurses, while incorporating reviews of patient-directed educational resources, self-management tips, and caregiver-support strategies. Register here.

This activity is supported by an educational grant from Teva CNS.


April Hazard Vallerand, PhD, RN, FAAN

Professor, Wayne State University College of Nursing

Neal E. Slatkin, MD

Chief Medical Officer and Vice President of Medical Services, Hospice of the Valley

Michelle Rhiner, MSN, NP

Instructor, Family Practice, Loma Linda University School of Medicine

Friday May 2, 2014 6:00am - 7:30am PDT
Marquis Ballroom Center Anaheim Marriott Hotel, 700 W. Convention Way, Anaheim, CA 92802
  Industry Event

Attendees (0)